Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting claudin-4 enhances chemosensitivity in breast cancer.
Luo Y, Kishi S, Sasaki T, Ohmori H, Fujiwara-Tani R, Mori S, Goto K, Nishiguchi Y, Mori T, Kawahara I, Kondoh M, Kuniyasu H. Luo Y, et al. Among authors: kondoh m. Cancer Sci. 2020 May;111(5):1840-1850. doi: 10.1111/cas.14361. Epub 2020 Mar 18. Cancer Sci. 2020. PMID: 32086991 Free PMC article.
A novel tumor-targeted therapy using a claudin-4-targeting molecule.
Saeki R, Kondoh M, Kakutani H, Tsunoda S, Mochizuki Y, Hamakubo T, Tsutsumi Y, Horiguchi Y, Yagi K. Saeki R, et al. Among authors: kondoh m. Mol Pharmacol. 2009 Oct;76(4):918-26. doi: 10.1124/mol.109.058412. Epub 2009 Jul 28. Mol Pharmacol. 2009. PMID: 19638534
Mucosal vaccination using claudin-4-targeting.
Kakutani H, Kondoh M, Fukasaka M, Suzuki H, Hamakubo T, Yagi K. Kakutani H, et al. Among authors: kondoh m. Biomaterials. 2010 Jul;31(20):5463-71. doi: 10.1016/j.biomaterials.2010.03.047. Biomaterials. 2010. PMID: 20398936
A claudin-targeting molecule as an inhibitor of tumor metastasis.
Saeki R, Kondoh M, Kakutani H, Matsuhisa K, Takahashi A, Suzuki H, Kakamu Y, Watari A, Yagi K. Saeki R, et al. Among authors: kondoh m. J Pharmacol Exp Ther. 2010 Aug;334(2):576-82. doi: 10.1124/jpet.110.168070. Epub 2010 May 4. J Pharmacol Exp Ther. 2010. PMID: 20442222
Efficacy and safety evaluation of claudin-4-targeted antitumor therapy using a human and mouse cross-reactive monoclonal antibody.
Hashimoto Y, Kawahigashi Y, Hata T, Li X, Watari A, Tada M, Ishii-Watabe A, Okada Y, Doi T, Fukasawa M, Kuniyasu H, Yagi K, Kondoh M. Hashimoto Y, et al. Among authors: kondoh m. Pharmacol Res Perspect. 2016 Sep 27;4(5):e00266. doi: 10.1002/prp2.266. eCollection 2016 Oct. Pharmacol Res Perspect. 2016. PMID: 27713828 Free PMC article.
360 results